News

Filter

Current filters:

Europe

1 to 9 of 478 results

EMA validates Biogen and AbbVie’s Zinbryta MAA for multiple sclerosis

27-03-2015

The European Medicines Agency has validated the Marketing Authorization Application for US biotech firms…

AbbVieBiogenBiotechnologydaclizumabEuropeNeurologicalRegulationZinbryta

German exemptions from mandatory rebates for pharma companies approved by EC

German exemptions from mandatory rebates for pharma companies approved by EC

27-03-2015

Following an in-depth investigation, the European Commission has concluded that a German scheme exempting…

EuropeFinancialGermanyLegalPharmaceuticalPricing

Orexigen's Mysimba approved in the EU for obese and overweight patients with co-morbidities

Orexigen's Mysimba approved in the EU for obese and overweight patients with co-morbidities

27-03-2015

Obesity speciality Orexigen has been granted marketing authorization by the European Commission for Mysimba…

EuropeMetabolicsMysimbaOrexigen TherapeuticsPharmaceuticalRegulation

Sepsis-specific treatment market set to grow to $354 million in 2021; report

26-03-2015

Following the first sepsis-specific product launch in 2016, the treatment market will expand at a compound…

Antibiotics and Infectious diseasesART-123Asahi Kasei PharmaEli LillyEuropeMarkets & MarketingPharmaceuticalUSAXigris

Transparency and cooperation help to reduce high prices for new medicines, WHO study shows

26-03-2015

As the number of new medicines introduced in Europe rises, governments are finding it increasingly difficult…

EuropeHealthcarePharmaceuticalPricing

European Commission approves Santen Pharma’s Ikervis for eye disease

25-03-2015

Japanese drugmaker Santen Pharmaceutical has received approval of the Marketing Authorization Application…

EuropeIkervisOphthalmicsPharmaceuticalRegulationSanten Pharmaceuticals

Novo Nordisk’s Saxenda gains EU approval for obesity

24-03-2015

There was good news for Danish diabetes care giant Novo Nordisk yesterday, when, late in the day, the…

DiabetesEuropeMetabolicsNovo NordiskPharmaceuticalRegulationSaxendaVictoza

Confluence Pharma inks deal with AOP Orphan for Fragile X syndrome drug

23-03-2015

Privately-held USA-based Confluence Pharmaceuticals and Austria’s AOP Orphan Pharmaceuticals have signed…

AOP Orphan PharmaceuticalsBiotechnologyConfluence PharmaceuticalsEuropeLicensingMarkets & MarketingRare diseases

1 to 9 of 478 results

Back to top